Ken Griffin’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-70,068
Closed -$3.71M 6824
2025
Q1
$3.71M Buy
70,068
+29,649
+73% +$1.57M ﹤0.01% 2018
2024
Q4
$2.26M Sell
40,419
-62,359
-61% -$3.49M ﹤0.01% 2475
2024
Q3
$5.38M Buy
+102,778
New +$5.38M ﹤0.01% 1708
2024
Q2
Sell
-4,098
Closed -$178K 6691
2024
Q1
$178K Sell
4,098
-109,817
-96% -$4.76M ﹤0.01% 4847
2023
Q4
$5.24M Sell
113,915
-141,518
-55% -$6.51M ﹤0.01% 1619
2023
Q3
$5.86M Buy
255,433
+65,901
+35% +$1.51M ﹤0.01% 1506
2023
Q2
$3.13M Sell
189,532
-175,508
-48% -$2.89M ﹤0.01% 2062
2023
Q1
$6.51M Buy
365,040
+294,342
+416% +$5.25M ﹤0.01% 1615
2022
Q4
$2.06M Buy
70,698
+14,863
+27% +$433K ﹤0.01% 2551
2022
Q3
$1.37M Sell
55,835
-112,223
-67% -$2.75M ﹤0.01% 3105
2022
Q2
$698K Sell
168,058
-81,866
-33% -$340K ﹤0.01% 3798
2022
Q1
$2.88M Buy
+249,924
New +$2.88M ﹤0.01% 2617
2021
Q4
Hold
0
7087
2021
Q3
Sell
-32,574
Closed -$638K 6986
2021
Q2
$638K Sell
32,574
-86,134
-73% -$1.69M ﹤0.01% 4486
2021
Q1
$2.53M Buy
118,708
+40,662
+52% +$865K ﹤0.01% 2910
2020
Q4
$2.32M Buy
78,046
+49,648
+175% +$1.48M ﹤0.01% 2421
2020
Q3
$615K Buy
+28,398
New +$615K ﹤0.01% 3318
2020
Q2
Sell
-20,758
Closed -$316K 5206
2020
Q1
$316K Buy
+20,758
New +$316K ﹤0.01% 3756
2019
Q1
Sell
-14,521
Closed -$391K 4957
2018
Q4
$391K Buy
14,521
+671
+5% +$18.1K ﹤0.01% 3417
2018
Q3
$404K Sell
13,850
-36,365
-72% -$1.06M ﹤0.01% 3295
2018
Q2
$1.57M Sell
50,215
-4,084
-8% -$128K ﹤0.01% 2317
2018
Q1
$1.08M Sell
54,299
-147,529
-73% -$2.94M ﹤0.01% 2402
2017
Q4
$5.87M Buy
+201,828
New +$5.87M ﹤0.01% 1224